|
Issue |
Title |
|
Vol 24, No 3 (2025) |
D-dimer as a risk factor for cardiovascular events in patients with liver diseases |
Abstract
PDF (Rus)
|
O. A. Rubanenko, I. A. Zolotovskaya, P. R. Shatskaya |
|
Vol 24, No 2 (2025) |
Personalized approach to the treatment of patients with arterial hypertension: focus on imidazoline receptor agonists. Opinion on the problem |
Abstract
PDF (Rus)
|
E. I. Baranova, V. Ionin, O. P. Rotar |
|
Vol 23, No 12 (2024) |
Risk factors and prevention of cardiovascular complications in breast cancer |
Abstract
PDF (Rus)
|
M. N. Mamedov, A. K. Karimov, E. K. Saribekyan, A. D. Zikiryakhodjaev |
|
Vol 23, No 12 (2024) |
From life history theory to clinical practice: potential markers of fast life strategy |
Abstract
PDF (Rus)
|
O. T. Kim, O. M. Drapkina |
|
Vol 23, No 12 (2024) |
MYBPC3-associated cardiomyopathy: features of the course and prospects for specific therapy |
Abstract
PDF (Rus)
|
D. A. Nefedova, R. P. Myasnikov, O. V. Kulikova, O. M. Drapkina |
|
Vol 24, No 1 (2025) |
On the practice of rapid blood pressure reduction with oral medications. A scientific view |
Abstract
PDF (Rus)
|
A. D. Erlikh, A. V. Rodionov, I. S. Yavelov, D. Yu. Shchekochikhin, V. V. Kashtalap, S. Yu. Martsevich, S. T. Matskeplishvili |
|
Vol 23, No 9 (2024) |
Oscillometric method: what is it and is it suitable for measuring blood pressure in all patients? |
Abstract
PDF (Rus)
|
I. N. Posokhov, N. N. Maroz-Vadalazhskaya |
|
Vol 23, No 9 (2024) |
Importance of biological markers in the assessment of endothelial dysfunction |
Abstract
PDF (Rus)
|
Yu. S. Timofeev, M. A. Mikhailova, O. N. Dzhioeva, O. M. Drapkina |
|
Vol 23, No 9 (2024) |
Cardiorenal continuum: clinical and pathogenetic relationships between heart failure with preserved ejection fraction and renal tubular dysfunction |
Abstract
PDF (Rus)
|
E. S. Levitskaya, M. M. Batyushin, D. I. Zakusilov, A. M. Batyushina |
|
Vol 23, No 8 (2024) |
Current approaches to the treatment of hypertensive patients in view of modern guidelines |
Abstract
PDF (Rus)
|
E. A. Polyakova, A. O. Konradi, E. I. Baranova, A. S. Galyavich, V. A. Ionin, O. D. Ostroumova, V. V. Skibitsky, G. A. Chumakova |
|
Vol 23, No 6 (2024) |
Relationship between microplastics and cardiovascular risk factors |
Abstract
PDF (Rus)
|
M. N. Mamedov, E. A. Savchuk |
|
Vol 23, No 6 (2024) |
Methodology for venous outflow assessment during ultrasound of extracranial vessels: status of the problem |
Abstract
PDF (Rus)
|
N. V. Korneeva, M. A. Lovrikova, K. V. Zhmerenetsky |
|
Vol 23, No 6 (2024) |
Recurrent myocardial infarction as an unsolved problem of evidence-based medicine |
Abstract
PDF (Rus)
|
S. Yu. Martsevich |
|
Vol 23, No 6 (2024) |
Ten-year cardiovascular risk estimation in type 2 diabetes in Europe using the novel SCORE2-Diabetes model |
Abstract
PDF (Rus)
|
G. G. Arabidze, M. N. Mamedov, H. R. Akhundova |
|
Vol 23, No 1 (2024) |
Cardiovascular complications in non-cardiac surgery: what remains out of sight? |
Abstract
PDF (Rus)
|
S. S. Murashko, S. A. Berns, I. N. Pasechnik |
|
Vol 23, No 1 (2024) |
Is meta-analysis the "top of the evidence pyramid" in cardiology? |
Abstract
PDF (Rus)
|
S. Yu. Martsevich |
|
Vol 23, No 12 (2024) |
Issues of concern and development of classifications of the main parameters of therapy quality and compliance. Part III: quality of pharmacotherapy |
Abstract
PDF (Rus)
|
Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. M. Drapkina |
|
Vol 22, No 8 (2023) |
Eating behavior: disorders and how to assess them |
Abstract
PDF (Rus)
|
S. O. Eliashevich, D. D. Nunes Araukho, O. M. Drapkina |
|
Vol 22, No 6 (2023) |
Clinical significance of distal embolism in intravascular recanalization of the superficial femoral artery |
Abstract
PDF (Rus)
|
O. S. Osipova, A. A. Gostev, A. A. Karpenko |
|
Vol 22, No 8 (2023) |
Sex and gender differences in health and disease. Part I. Evolutionary |
Abstract
PDF (Rus)
|
O. M. Drapkina, O. T. Kim |
|
Vol 22, No 2S (2023): Professional Education |
Formation of social communication skills among students of the Faculty of Medicine in the system of professional education. Experience of the Republic of Kazakhstan |
Abstract
PDF (Rus)
|
K. Kidirbayeva, Sh Satiyeva, Zh Kuanyshbayeva, A. Iskakova, G. I. Assanova, G. Роvalyashko, Zh. Duisenbekova |
|
Vol 22, No 2S (2023): Professional Education |
Problems of domestic school natural science education, patriotism promotion and their influence on the training of medical professionals |
Abstract
PDF (Rus)
|
N. A. Bogdanov, A. P. Aniskina |
|
Vol 22, No 2S (2023): Professional Education |
In search of a modern character of a doctor: what examples to learn from the greats? Part I |
Abstract
PDF (Rus)
|
Yu. V. Rodionova |
|
Vol 22, No 1S (2023): Профессиональное образование |
Concept of developing a professional outlook of a future doctor based on an integrative approach |
Abstract
PDF (Rus)
|
L. V. Chichanovskaya, E. A. Evstifeeva, A. V. Solovieva, O. N. Bakhareva, L. A. Murashova, R. N. Chirkov, S. A. Sokolov, O. A. Gavrilova |
|
Vol 22, No 1S (2023): Профессиональное образование |
Continuity and orientation of the pedagogical process in a medical university |
Abstract
PDF (Rus)
|
Е/ N. Skryabina, Natalia M. Nikitina |
|
Vol 21, No 8 (2022) |
Office blood pressure: overcoming the problems of diagnosis and control of arterial hypertension treatment |
Abstract
PDF (Rus)
|
E. V. Platonova, E. Yu. Fedorova, V. M. Gorbunov |
|
Vol 21, No 1 (2022) |
Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice |
Abstract
PDF (Rus)
PDF (Eng)
|
S. A. Shalnova |
|
Vol 21, No 1S (2022): Профессиональное образование |
Role of pedagogy and psychology in the development of self-actualization and value orientations of medical residents |
Abstract
PDF (Rus)
|
M. I. Plugina, T. A. Maiboroda |
|
Vol 20, No 7 (2021) |
Atherosclerosis pathogenesis from the perspective of microvascular dysfunction |
Abstract
PDF (Rus)
PDF (Eng)
|
D. M. Aronov, M. G. Bubnova, O. M. Drapkina |
|
Vol 20, No 1 (2021) |
Heyde’s syndrome as a rare cause of gastrointestinal bleeding in aortic stenosis patients |
Abstract
PDF (Rus)
|
D. V. Belov, D. V. Garbuzenko, O. P. Lukin, S. S. Anufrieva |
|
Vol 20, No 1 (2021) |
Novel algorithms for diagnosing heart failure with preserved ejection fraction in patients with hypertension and obesity |
Abstract
PDF (Rus)
|
Yu. A. Vasyuk, E. Yu. Shupenina, G. A. Namazova, T. I. Dubrovskaya |
|
Vol 20, No 1 (2021) |
Risk factors for cardiovascular diseases and coronary artery disease among military population |
Abstract
PDF (Rus)
|
A. E. Masimova, M. N. Mamedov |
|
Vol 19, No 6 (2020) |
Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part I |
Abstract
PDF (Rus)
|
A. S. Safaryan, V. D. Sargsyan |
|
Vol 19, No 1 (2020) |
Prospects for Raman spectroscopy in cardiology |
Abstract
PDF (Rus)
|
V. V. Rafalsky, A. Yu. Zyubin, E. M. Moiseeva, I. G. Samusev |
|
Vol 19, No 1 (2020) |
Pharmaceutical advertising on child-focused television networks in Russia: is there a need for change? |
Abstract
PDF (Rus)
|
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina |
|
Vol 18, No 5 (2019) |
Associations of absolute risk of osteoporotic fractures (FRAX®) and total cardiovascular risk (SCORE) in urban population of the Russian Federation |
Abstract
PDF (Rus)
|
M. A. Myagkova, I. A. Skripnikova, O. V. Kosmatova, S. A. Shalnova, V. A. Vygodin |
|
Vol 18, No 5 (2019) |
Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors |
Abstract
PDF (Rus)
|
O. D. Ostroumova, E. A. Volkova, A. I. Kochetkov, A. P. Pereverzev, O. N. Tkacheva |
|
Vol 18, No 5 (2019) |
Analytical complex of biochemical markers for preclinical diagnosis and prevention of cardiovascular diseases |
Abstract
PDF (Rus)
|
N. G. Gumanova |
|
Vol 18, No 6 (2019) |
Virtual patients with cardiovascular pathology: technology for postgraduate medical education |
Abstract
PDF (Rus)
|
S. I. Karas, M. B. Arzhanik, A. E. Baev, V. Kh. Vaizov, O. Ya. Vasiltseva, E. V. Grakova, V. M. Gulyaev, K. V. Zavadovsky, E. E. Kara-Sal, W. Yu. Ussov |
|
Vol 18, No 6 (2019) |
New treatment options for pulmonary arterial hypertension — the first selective IP-receptor agonist selexipag |
Abstract
PDF (Rus)
|
N. V. Ilyin, K. I. Ivanov, T. V. Martynyuk |
|
Vol 18, No 6 (2019) |
Statins and the risk of cataract |
Abstract
PDF (Rus)
|
E. K. Butina, E. V. Bochkareva, I. V. Kim |
|
Vol 18, No 6 (2019) |
Modern considerations of myocardial revascularization in coronary chronic total occlusion |
Abstract
PDF (Rus)
|
D. K. Vasiliev, B. A. Rudenko |
|
Vol 18, No 6 (2019) |
Endothelial dysfunction in hypertension: cause or effect? |
Abstract
PDF (Rus)
|
A. Yu. Gorshkov, A. A. Fedorovich, O. M. Drapkina |
|
Vol 18, No 6 (2019) |
New directions in metabolic syndrome diagnosis: assessment of vascular endothelial growth factor, pentraxin-3 and transforming growth factor beta levels |
Abstract
PDF (Rus)
|
R. N. Shepel, O. M. Drapkina |
|
Vol 18, No 4 (2019) |
The role of obesity in the development of atrial fibrillation: current problem status |
Abstract
PDF (Rus)
|
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin, K. A. Oganesyan, N. V. Lobova |
|
Vol 18, No 4 (2019) |
Sociocultural factors in the cardiovascular continuum |
Abstract
PDF (Rus)
|
E. O. Taratukhin |
|
Vol 18, No 3 (2019) |
Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period |
Abstract
PDF (Rus)
|
A. E. Khrulev, A. A. Nikitina, N. S. Khruleva |
|
Vol 18, No 3 (2019) |
Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow |
Abstract
PDF (Rus)
|
V. I. Podzolkov, A. I. Tarzimanova |
|
Vol 18, No 1 (2019) |
Factors and mechanisms of arterial hypertension development in patients with atherosclerosis of lower limb arteries |
Abstract
PDF (Rus)
|
E. M. Evsikov, V. I. Vechorko, N. V. Teplova, M. H. Zhapueva, N. G. Artamonova |
|
Vol 18, No 1 (2019) |
Attitude to health and disease prevention of as a parameter of public health |
Abstract
PDF (Rus)
|
O. V. Senatorova, V. A. Kuznetsov, A. S. Trufanov |
|
Vol 17, No 6 (2018) |
Treatment of hypertension in obese patients: focus on telmisartan |
Abstract
PDF (Rus)
|
I. E. Deneka, A. V. Rodionov, V. V. Fomin |
|
Vol 17, No 6 (2018) |
Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinic and diagnostics |
Abstract
PDF (Rus)
|
R. E. Tokmachev, M. S. Mukhortova, A. V. Budnevsky, E. V. Tokmachev, E. S. Ovsyannikov |
|
Vol 17, No 5 (2018) |
New АСС/AHA and ESC/ESH arterial hypertension guidelines |
Abstract
PDF (Rus)
|
E. V. Reznik, I. G. Nikitin |
|
Vol 17, No 4 (2018) |
Modern endovascular methods in treatment of patients with the tibial arteries lesion: determinants and perspectives |
Abstract
PDF (Rus)
|
A. V. Cheban, A. A. Karpenko, I. V. Popova, Sh. B. Saaya, A. A. Gostev, А. A. Rabtsun, О. A. Novikova, P. P. Laktionov |
|
Vol 17, No 3 (2018) |
MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS |
Abstract
PDF (Rus)
|
G. G. Sharvadze, R. R. Dalari, B. U. Mardanov, M. N. Mamedov |
|
Vol 17, No 3 (2018) |
COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY |
Abstract
PDF (Rus)
|
L. N. Uddin, M. A. Gabitova, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, D. V. Vychuzhanin, A. V. Egorov, V. V. Fomin |
|
Vol 17, No 2 (2018) |
NUCLEAR IMAGING IN SUDDEN CARDIAC DEATH RISK ASSESSMENT |
Abstract
PDF (Rus)
|
A. A. Ansheles, К. V. Zavadovsky, S. I. Sazonova, V. B. Sergienko, R. S. Karpov |
|
Vol 17, No 2 (2018) |
PREDICTION SCORE IN SURGICAL COMPLICATIONS ESTIMATION IN THE PRACTICE OF INTERNIST |
Abstract
PDF (Rus)
|
D. P. Kotova, S. V. Kotov, M. Yu. Gilyarov, V. S. Shemenkova |
|
Vol 17, No 2 (2018) |
APPROACHES TO STATIN THERAPY ADHERENCE IMPROVEMENT |
Abstract
PDF (Rus)
|
S. A. Shalnova, V. N. Belov, M. N. Valiakhmetov, N. G. Veselovskaya, N. V. Voronina, A. V. Dmitriev, E. V. Efremova, L. О. Minushkina, A. М. Naydich, V. Yu. Pavlova, Ya. M. Pakhomov, A. Е. Rivin, L. I. Feiskhanova, Е. V. Khorolets, О. P. Askerko, E. Z. Topuridze |
|
Vol 16, No 6 (2017) |
TREATMENT ADHERENCE AS AN ESSENTIAL ELEMENT OF CARDIOVASCULAR DISORDERS MANAGEMENT |
Abstract
PDF (Rus)
|
D. V. Nebieridze, T. V. Kamyshova, A. S. Safaryan, V. D. Sargsyan |
|
Vol 16, No 6 (2017) |
RETRACTED: CARDIOMETABOLIC DISORDERS AND UROLITHIASIS: PATHOGENESIS OF COMORBIDITY |
Abstract
PDF (Rus)
|
G. G. Sharvadze, A. К. Kerimov, М. N. Mamedov |
|
Vol 16, No 5 (2017) |
POSITIVE EXPERIENCE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USAGE IN CARDIOLOGICAL PATIENTS |
Abstract
PDF (Rus)
|
R. G. Oganov |
|
Vol 16, No 5 (2017) |
BODY COMPOSITION AND ITS ROLE IN DEVELOPMENT OF METABOLIC DISORDERS AND CARDIOVASCULAR DISEASES |
Abstract
PDF (Rus)
|
O. M. Drapkina, L. V. Kupreyshvili, V. V. Fomin |
|
Vol 16, No 5 (2017) |
SLEEP DISORDERS AND THE RISK OF ARTERIAL HYPERTENSION AND STROKE IN OPEN FEMALE POPULATION 25-64 YEAR OLD IN RUSSIA/SIBERIA (POPULATIONAL STUDY — WHO PROGRAM “MONICA-PSYCHOSOCIAL”) |
Abstract
PDF (Rus)
|
V. V. Gafarov, D. O. Panov, E. A. Gromova, I. V. Gagulin, A. V. Gafarova |
|
Vol 16, No 5 (2017) |
COMORBID PATIENT IN THE INTERNAL MEDICINE: CARDIOVASCULAR DISEASES AND ANXIETY |
Abstract
PDF (Rus)
|
G. B. Selivanova |
|
Vol 16, No 4 (2017) |
PRIMARY (GENETICALLY DETERMINED) DILATION CARDIOMYOPATHY IN A PATIENT WITH NOVEL MUTATION OF LAMIN GENE: CLINICAL AND MORPHOLOGICAL MANAGEMENT |
Abstract
PDF (Rus)
|
O. V. Blagova, I. N. Alieva, A. V. Nedostup, V. A. Sulimov, E. A. Kogan, A. G. Shestak, D. A. Zateyshchikov, E. V. Zaklyazminskaya |
|
Vol 16, No 4 (2017) |
PULSE WAVE VELOCITY AS A NOVEL RISK FACTOR FOR CHRONIC KIDNEY DISEASE PROGRESSION |
Abstract
PDF (Rus)
|
I. T. Murkamilov, K. A. Aitbaev, F. A. Yusupov |
|
Vol 16, No 4 (2017) |
MYOCARDIAL INFARCTION AND THE ISSUE OF INDIVIDUALIZED MANAGEMENT. CLINICAL CASE OF SPONTANEOUS DISSECTION IN TWO CORONARY ARTERIES |
Abstract
PDF (Rus)
|
M. N. Arefiev, L. L. Klykov, V. V. Krylov, V. A. Rusina, E. O. Taratukhin |
|
Vol 16, No 3 (2017) |
ACUTE CORONARY SYNDROME IN ELDERLY: CURRENT STATUS AND UNRESOLVED ISSUES |
Abstract
PDF (Rus)
|
О. N. Tkacheva, Yu. V. Kotovskaya, К. V. Feoktistova, V. S. Ostapenko, I. A. Osadchiy, S. M. Khokhlunov, N. К. Runikhina, D. V. Dyplyakov |
|
Vol 16, No 3 (2017) |
OBSTRUCTIVE SLEEP APNEA AS CARDIOVASCULAR RISK FACTOR: TO TREAT OR NOT? |
Abstract
PDF (Rus)
|
О. M. Drapkina, Yu. V. Dubolazova, О. N. Korneeva |
|
Vol 16, No 2 (2017) |
TOWARDS A CLASSIFICATION ISSUE OF PSYCHIATRIC DISORDERS IN CARDIOLOGY (DISPUTABLE ASPECTS OF THE ARTICLE BY DROBIZHEV M. YU., KIKTA S.V., MACHILSKY O.V., “CARDIOPSYCHIATRY. TRANSLATION ISSUES”) |
Abstract
PDF (Rus)
|
B. A. Volel |
|
Vol 16, No 2 (2017) |
THE ROLE OF DIET AND PHYSICAL ACTIVITY IN THERAPY OF CARDIOVASCULAR PATIENTS WITH NORMAL EJECTION FRACTION |
Abstract
PDF (Rus)
|
O. M. Drapkina, Yu. V. Duboglazova, S. O. Eliashevich |
|
Vol 16, No 2 (2017) |
CARDIOPSYCHIATRY. A CLASH OF OPINIONS |
Abstract
PDF (Rus)
|
M. Yu. Drobizhev |
|
Vol 16, No 1 (2017) |
TREATMENT ADHERENCE: MODERN VIEW ON A WELL KNOWN ISSUE |
Abstract
PDF (Rus)
|
Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich |
|
Vol 16, No 1 (2017) |
ON THE RELATION OF STROKE AND AIR POLLUTION WITH PARTICULATE MATTER. PREVENTION ACTIONS |
Abstract
PDF (Rus)
|
A. F. Kolpakova |
|
Vol 16, No 1 (2017) |
NON-COMPACTION MYOCARDIUM OF THE LEFT VENTRICLE: SECONDARY PREVENTION OF THROMBOEMBOLISM |
Abstract
PDF (Rus)
|
R. P. Myasnikov, О. V. Kulikova, М. S. Kharlap, S. N. Koretsky, Е. Yu. Andreenko, E. A. Mershina, V. Е. Sinitsin, S. А. Boytsov |
|
Vol 15, No 6 (2016) |
AN ISSUE OF THE PATIENTS ROUTING IN CASE OF PULMONARY EMBOLISM |
Abstract
PDF (Rus)
|
O. Ya. Vasiltseva, I. N. Vorozhtsova, I. Kh. Selivanova, A. A. Gorlova, R. S. Karpov |
|
Vol 15, No 6 (2016) |
DECOMPENSATED CHRONIC HEART FAILURE: FROM PATHOGENESIS TO PROGNOSIS |
Abstract
PDF (Rus)
|
K. S. Fazulina |
|
Vol 15, No 5 (2016) |
Modern ECG-based systems for cardiovascular functioning express-evaluation |
Abstract
PDF (Rus)
|
M. D. Podolsky, A. A. Strokov, V. I. Kuznetsov, V. V. Shapovalov |
|
Vol 15, No 4 (2016) |
A COMPLEX ASSESSMENT OF COMBINATION DRUG THERAPY IN CARDIOVASCULAR COMORBIDITY |
Abstract
PDF (Rus)
|
Yu. V. Luneva, E. I. Bezuglova, S. V. Povetkin, A. A. Kornilov |
|
Vol 15, No 4 (2016) |
PREDICTIVE VALUE OF CARDIAC CACHEXIA IN CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
E. S. Drobysheva, R. E. Tokmachev, A. V. Budnevsky, A. Ya. Kravchenko |
|
Vol 15, No 4 (2016) |
DOES THE “OBESITY PARADOX” REALLY TAKE PLACE IN CORONARY HEART DISEASE? |
Abstract
PDF (Rus)
|
O. M. Drapkina, R. N. Shepel, S. O. Eliashevich |
|
Vol 15, No 3 (2016) |
THE INFLUENCE OF PSYCHOSOCIAL FACTORS ON THE DEVELOPMENT OF ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME |
Abstract
PDF (Rus)
|
K. G. Kozhokar, I. A. Urvantceva, K. Yu. Nikolaev |
|
Vol 15, No 3 (2016) |
ASSOCIATION OF THE GENE CYP11B2 WITH THE RISK OF ESSENTIAL HYPERTENSION AND ATHEROTHROMBOTIC COMPLICATIONS |
Abstract
PDF (Rus)
|
E. M. Zelenskaya, N. V. Koch, V. V. Kireeva, K. A. Apartsin, G. I. Lifshitz |
|
Vol 15, No 2 (2016) |
Effective tissue antiischemic therapy of etiologically various vascular diseases of the brain |
Abstract
PDF (Rus)
|
A. L. Vertkin |
|
Vol 15, No 2 (2016) |
Is cardiovascular risk factors prevention necessary from childhood? What do prospective studies show |
Abstract
PDF (Rus)
|
A. A. Alexandrov, V. B. Rozanov, E. Yu. Zvolinskaya, Kh. S. Pugoeva |
|
Vol 15, No 1 (2016) |
Gut microbiota and cardiovascular risk factors. Part IV. Arterial hypertension, smoking and the gut microbiota |
Abstract
PDF (Rus)
|
D. A. Kashtanova, O. N. Tkacheva, S. A. Boytsov |
|
Vol 15, No 1 (2016) |
The influence of anemia on cardiovascular disease course |
Abstract
PDF (Rus)
|
A. V. Budnevsky, E. S. Ovsyannikov, A. V. Red`ka |
|
Vol 15, No 1 (2016) |
Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid |
Abstract
PDF (Rus)
|
V. V. Rafalsky, A. N. Kisilyova, S. O. Krikova, S. O. Losenkova, E. G. Kogan, M. E. Shatalova |
|
Vol 14, No 6 (2015) |
STATINS IN CHRONIC KIDNEY DISEASE. IS THERE A DRUG OF CHOICE? |
Abstract
PDF (Rus)
|
O. M. Drapkina, O. N. Korneeva |
|
Vol 14, No 6 (2015) |
GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART III. LIPID PROFILE, CARBOHYDRATE METABOLISM AND GUT MICROBIOTA |
Abstract
PDF (Rus)
|
O. N. Tkacheva, D. A. Kashtanova, S. A. Boytsov |
|
Vol 14, No 5 (2015) |
THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION |
Abstract
PDF (Rus)
|
R. P. Myasnikov, O. V. Blagova, O. V. Kulikova, E. A. Mershina, M. S. Kharlap, E. Yu. Andreenko, S. N. Koretsky, S. E. Serdyuk, E. V. Bazaeva, I. A. Virabova, S. A. Beregovskaya, V. E. Sinitsyn, S. A. Boytsov |
|
Vol 14, No 4 (2015) |
THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES |
Abstract
PDF (Rus)
|
N. A. Koziolova, Е. А. Polyanskaya |
|
Vol 14, No 4 (2015) |
PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
Yu. M. Lopatin, E. Yu. Lopatina |
|
Vol 14, No 3 (2015) |
STUDY OF SOME ANTIHYPERTENSION DRUGS USE IN CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
N. A. Konyshko, T. E. Morozova |
|
Vol 14, No 1 (2015) |
THE WAYS OF LONG-TERM BLOOD PRESSURE CONTROL SYSTEMS DEVELOPMENT |
Abstract
PDF (Rus)
|
S. A. Rumyantseva, V. A. Stupin, R. G. Oganov, E. V. Silina, E. A. Kolesnikova, V. A. Petrov, V. A. Kasymov, N. N. Shusharina, D. V. Ladaniy, E. A. Bogdanov |
|
Vol 14, No 1 (2015) |
TELOMERES AND TELOMERASE COMPLEX. THE MAIN CLINICAL MANIFESTATION OF GENETIC MALFUNCTIONING |
Abstract
PDF (Rus)
|
О. М. Drapkina, R. N. Shepel |
|
Vol 13, No 6 (2014) |
MORBIDITY AND MORTALITY FROM CARDIOVASCULAR DISEASES ACCORDING TO THE SEA-LEVEL RELATED ALTITUDE OF A REGION |
Abstract
PDF (Rus)
|
A. A. Dotdaeva, Kh. A. Kurdanov, S. A. Boytsov |
|
Vol 13, No 6 (2014) |
GUT ENTEROBIOTA — A NEW PLAYER IN ATHEROSCLEROSIS PATHOGENESIS |
Abstract
PDF (Rus)
|
L. V. Egshatyan, O. N. Tkacheva, S. A. Boytsov |
|
Vol 13, No 4 (2014) |
MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS |
Abstract
PDF (Rus)
|
V. I. Petrov, O. V. Shatalova, A. S. Maslakov, A. V. Kushkinova |
|
Vol 13, No 4 (2014) |
NOVEL OPPORTUNITIES TO REACH THE TARGET LEVELS OF LOW DENSITY CHOLESTEROL |
Abstract
PDF (Rus)
|
M. V. Ezhov |
|
Vol 13, No 4 (2014) |
THE PRIMARY CARE PHYSICIAN ROLE IN PRIMARY STROKE PREVENTION. THE PLACE FOR ANTIHYPERTENSIVE THERAPY |
Abstract
PDF (Rus)
|
S. Yu. Martsevich, N. P. Kutishenko |
|
Vol 13, No 3 (2014) |
THE ROLE OF OBSERVATIONAL POPULATION STUDIES (REGISTERS) IN THE IMPROVEMENT OF CARDIOVASCULAR CARE |
Abstract
PDF (Rus)
|
N. A. Mazur |
|
Vol 13, No 3 (2014) |
ANEMIC PATIENT AT GP’S OFFICE |
Abstract
PDF (Rus)
|
A. L. Vertkin, N. O. Khovasova, E. D. Laryushkina, K. I. Shamaeva |
|
Vol 13, No 2 (2014) |
SPECIFIC PROPERTIES OF THE DRUG THERAPY FOR STABLE ANGINA IN MEN |
Abstract
PDF (Rus)
|
R. G. Oganov, G. Ya. Maslennikova |
|
Vol 13, No 2 (2014) |
EARLY HEART DISORDERS IN HYPERTENSIVE PERSONS AS THE RESULTS OF PREVENTIVE EXAMINATION ON INDUSTRIAL ENTERPRISE |
Abstract
PDF (Rus)
|
A. N. Britov, E. M. Platonova, T. V. Ryzova, N. A. Eliseeva |
|
Vol 13, No 2 (2014) |
ТHE ROLE OF GENETIC TESTING FOR OPTIMAL ANTIPLATELET THERAPY SELECTION IN THE TREATMENT OF CORONARY ARTERY DISEASE PATIENTS |
Abstract
PDF (Rus)
|
S. T. Matskeplishvili, Y. E. Arutyunova |
|
Vol 13, No 2 (2014) |
A COMPARISON OF THE MAIN ANTIHYPERTENSIVE DRUGS FROM THE VIEWPOINT OF AORTIC STIFFNESS MODIFICATION IN ARTERIAL HYPERTENSION |
Abstract
PDF (Rus)
|
E. Yu. Shupenina, Yu. A. Vasyuk, A. B. Khadzegova, S. V. Ivanova, E. V. Nadina, A. M. Khuchinaeva |
|
Vol 13, No 1 (2014) |
COMBINED ACTION ANTIHYPERTENSIVE AGENT URAPIDIL: EFFECTIVENESS AND SAFETY IN CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
N. I. Gaponova, V. R. Abdrakhmanov, V. A. Kadyshev, A. Yu. Sokolov |
|
Vol 13, No 1 (2014) |
AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION |
Abstract
PDF (Rus)
|
L. L. Kirichenko, S. V. Gatsura, A. N. Golosova, K. V. Ovsyannikov, O. V. Budik, A. V. Fedorov |
|
Vol 12, No 6 (2013) |
OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS |
Abstract
PDF (Rus)
|
O. Yu. Shaidyuk, E. O. Taratukhin |
|
Vol 12, No 6 (2013) |
EXOME SEQUENCING AND THE DIAGNOSTICS OF COMPLEX DISEASE PREDISPOSITION IN PREVENTIVE MEDICINE |
Abstract
PDF (Rus)
|
N. V. Shcherbakova, A. N. Meshkov, S. A. Boytsov |
|
Vol 12, No 6 (2013) |
COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE? |
Abstract
PDF (Rus)
|
I. V. Zhirov, O. A. Nikolaeva, S. N. Tereshchenko |
|
Vol 12, No 5 (2013) |
ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE |
Abstract
PDF (Rus)
|
M. G. Glezer, E. I. Astashkin, I. N. Sokolova |
|
Vol 12, No 5 (2013) |
NEW PATHOGENETIC FACTORS OF ATHEROSCLEROSIS DEVELOPMENT AND POTENTIAL THERAPEUTIC APPROACHES |
Abstract
PDF (Rus)
|
I. Ya. Kalvinsh |
|
Vol 12, No 5 (2013) |
COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION |
Abstract
PDF (Rus)
|
L. O. Minushkina |
|
Vol 12, No 4 (2013) |
EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
Abstract
PDF (Rus)
|
A. Catapano, E. V. Shlyakhto, A. I. Martynov, R. G. Oganov, V. V. Kukharchuk, M. V. Shestakova, A. S. Ametov, S. A. Boicov, M. G. Bubnova, S. V. Villevalde, A. S. Galyavich, Yu. A. Karpov, J. D. Kobalava, O. N. Koziolova |
|
Vol 12, No 4 (2013) |
STROKE PREVENTION OPPORTUNITIES FOR CARDIOLOGISTS: COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION (ROLE OF CALCIUM ANTAGONISTS) |
Abstract
PDF (Rus)
|
E. O. Taratukhin |
|
Vol 12, No 4 (2013) |
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN |
Abstract
PDF (Rus)
|
V. V. Fomin |
|
Vol 12, No 3 (2013) |
ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES |
Abstract
PDF (Rus)
|
E. O. Taratukhin |
|
Vol 12, No 3 (2013) |
ECHOCARDIOGRAPHY IN RIGHT VENTRICULAR MYOCARDIAL INFARCTION |
Abstract
PDF (Rus)
|
H. G. Hayrapetyan, K. G. Adamyan |
|
Vol 12, No 3 (2013) |
A NEW COMBINATION INHIBITS INTESTINAL CHOLESTEROL ABSORPTION, SUPPRESSES ENDOGENOUS CHOLESTEROL SYNTHESIS, AND DEMONSTRATES ANTI-INFLAMMATORY AND HEPATOPROTECTIVE EFFECTS |
Abstract
PDF (Rus)
|
R. G. Oganov, S. I. Chernova, V. Yu. Gorbacheva |
|
Vol 12, No 3 (2013) |
COMBINATION ANTIHYPERTENSIVE THERAPY: WHEN THE WHOLE IS GREATER THAN THE SUM OF ITS PARTS |
Abstract
PDF (Rus)
|
E. O. Taratukhin, N. V. Teplova |
|
Vol 12, No 2 (2013) |
PATHOGENETIC TREATMENT OF ARTERIAL HYPERTENSION: THE PLACE OF CALCIUM ANTAGONISTS |
Abstract
PDF (Rus)
|
E. O. Taratukhin, N. N. Teplova |
|
Vol 12, No 2 (2013) |
EARLY DISTURBANCES OF CARBOHYDRATE METABOLISM — A TARGET FOR PRIMARY CARDIOVASCULAR PREVENTION |
Abstract
PDF (Rus)
|
M. N. Kovrigina, M. N. Mamedov |
|
Vol 12, No 2 (2013) |
MELDONIUM: EFFECTIVE ACTION POINTS |
Abstract
PDF (Rus)
|
A. L. Vertkin, N. O. Khovasova, V. V. Pshenichnikova, M. A. Alekseev, A. U. Abdullaeva |
|
Vol 12, No 1 (2013) |
CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION) |
Abstract
PDF (Rus)
|
E. V. Privalova, V. Yu. Kaplunova, N. V. Khabarova, G. A. Shakaryants, Yu. N. Belenkov |
|
Vol 12, No 1 (2013) |
POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE |
Abstract
PDF (Rus)
|
A. G. Evdokimova, V. V. Evdokimov |
|
Vol 12, No 1 (2013) |
ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS |
Abstract
PDF (Rus)
|
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein |
|
Vol 11, No 6 (2012) |
Pathogenetic therapy of heart failure: beta-adrenoblockers |
Abstract
PDF (Rus)
|
O. Yu. Shayduk, E. O. Taratukhin |
|
Vol 11, No 6 (2012) |
Antiplatelet drug resistance in patients with coronary heart disease |
Abstract
PDF (Rus)
|
V. A. Sulimov, E. V. Moroz |
|
Vol 11, No 6 (2012) |
Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists |
Abstract
PDF (Rus)
|
E. O. Taratukhin |
|
Vol 11, No 6 (2012) |
How to avoid statin hepatotoxicity in patients with obesity and liver disease? Focus on the combination of ursodeoxycholic acid and atorvastatin |
Abstract
PDF (Rus)
|
O. N. Korneeva, O. M. Drapkina |
|
Vol 11, No 5 (2012) |
Angioprotection role in arterial hypertension treatment: focus on olmesartan |
Abstract
PDF (Rus)
|
D. V. Nebieridze, A. S. Safaryan, T. V. Ivanishina, N. L. Vinnitskaya |
|
Vol 11, No 5 (2012) |
Enalapril: new possibilities |
Abstract
PDF (Rus)
|
E. O. Taratukhin |
|
Vol 11, No 4 (2012) |
Modern opportunities for optimising the treatment of patients with coronary heart disease and arterial hypertension: role of zofenopril |
Abstract
PDF (Rus)
|
A. G. Evdokimova, V. V. Evdokimov, N. V. Leonenko, A. V. Smetanin |
|
Vol 11, No 3 (2012) |
Vitamin D role in arterial hypertension development |
Abstract
PDF (Rus)
|
E. N. Dudinskaya, O. N. Tkacheva |
|
Vol 11, No 3 (2012) |
Subclinical atherosclerosis as a risk factor of cardiovascular events |
Abstract
PDF (Rus)
|
S. A. Boytsov, V. V. Kukharchuk, Yu. A. Karpov, I. V. Sergienko, O. M. Drapkina, A. E. Semenova, S. Zh. Urazalina |
|
Vol 11, No 3 (2012) |
Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment |
Abstract
PDF (Rus)
|
V. B. Mychka |
|
Vol 11, No 3 (2012) |
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension |
Abstract
PDF (Rus)
|
C. Napoli, G. Bruzzese, L. J. Ignarro, E. Crimi, F. de Nigris, S. Williams-Ignarro, S. Libardi, L. Sommese, C. Fiorito, F. P. Mancini, F. Cacciatore, A. Liguori |
|
Vol 11, No 2 (2012) |
Scientometric approaches to the analysis of research results |
Abstract
PDF (Rus)
|
R. G. Oganov, S. A. Trushchelev |
|
Vol 11, No 2 (2012) |
Subclinical atherosclerosis diagnostics as a component of a modern strategy for cardiovascular risk stratification |
Abstract
PDF (Rus)
|
N. O. Katamadze, L. L. Berstein, Yu. N. Grishkin |
|
Vol 11, No 2 (2012) |
Metabolic syndrome as a clinical manifestation of endothelial dysfunction |
Abstract
PDF (Rus)
|
L. L. Kirichenko, K. V. Ovsyannikov, A. N. Fedoseev, A. M. Shklyarov, A. P. Korolev |
|
Vol 11, No 1 (2012) |
Essential arterial hypertension in women, or female arterial hypertension? |
Abstract
PDF (Rus)
|
V. I. Podzolkov, A. E. Bragina |
|
Vol 11, No 1 (2012) |
Consensus Statement by the Expert Advisory Committee |
Abstract
PDF (Rus)
|
article Editorial |
|
Vol 10, No 6 (2011) |
The role of vasodilating β-blockers in patients with complicated hypertension: focus on nebivolol |
Abstract
PDF (Rus)
|
T. D. Giles |
|
Vol 10, No 6 (2011) |
Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease |
Abstract
PDF (Rus)
|
C. Napoli |
|
Vol 10, No 5 (2011) |
Double antiplatelet therapy in patients with acute coronary syndrome |
Abstract
PDF (Rus)
|
A. V. Rodionov, D. Kh. Aynetdinova, V. A. Sulimov |
|
Vol 10, No 5 (2011) |
A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations? |
Abstract
PDF (Rus)
|
M. Greathouse |
|
Vol 10, No 4 (2011) |
Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy |
Abstract
PDF (Rus)
|
L. I. Abasova, R. L. Dashdamirov, A. B. Bakhshaliev |
|
Vol 10, No 4 (2011) |
Ineffective statin monotherapy: alternative therapeutic strategy |
Abstract
PDF (Rus)
|
I. V. Sergienko |
|
Vol 10, No 4 (2011) |
Modern views on amlodipine and new S-amlodipine medications |
Abstract
PDF (Rus)
|
M. V. Leonova |
|
Vol 10, No 4 (2011) |
Venous thromboembolism in patients with heart failure |
Abstract
PDF (Rus)
|
O. V. Averkov, I. V. Shevchenko, T. Sh. Mirilashvili, Zh. D. Kobalava |
|
Vol 10, No 3 (2011) |
Metabolic (cytoprotective) therapy of menopausal disturbances |
Abstract
PDF (Rus)
|
S. N. Tolstov, V. B. Mychka |
|
Vol 10, No 3 (2011) |
Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features |
Abstract
PDF (Rus)
|
O. D. Ostroumova, E. A. Smolyarchuk |
|
Vol 10, No 2 (2011) |
Organo-protective effects of quinapril: pharmacogenetic aspects |
Abstract
PDF (Rus)
|
D. A. Sychev, O. V. Muslimova |
|
Vol 10, No 2 (2011) |
Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy |
Abstract
PDF (Rus)
|
V. V. Rafalskiy, A. N. Baglikov |
|
Vol 10, No 1 (2011) |
C-reactive protein: modern state of the problem |
Abstract
PDF (Rus)
|
V. A. Zhukova, S. A. Shalnova, V. A. Metelskaya |
|
Vol 9, No 6 (2010) |
High-risk patients: modern treatment strategy |
Abstract
PDF (Rus)
|
D. V. Nebieridze, A. Meliya |
|
Vol 9, No 6 (2010) |
Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment |
Abstract
PDF (Rus)
|
M. Yu. Gilyarov, V. A. Sulimov |
|
Vol 9, No 6 (2010) |
Cardiovascular health monitoring of the Russian population: practical implications |
Abstract
PDF (Rus)
|
S. A. Shalnova |
|
Vol 9, No 6 (2010) |
Russian cardiological clinical trials |
Abstract
PDF (Rus)
|
S. N. Tolpygina, S. A. Shalnova, S. Yu. Martsevich, N. V. Kiseleva |
|
Vol 9, No 6 (2010) |
NEBIVOLOL and the 2009 ESH update to the 2007 ESH/ESC Guidelines |
Abstract
PDF (Rus)
|
V. I. Makolkin |
|
Vol 9, No 5 (2010) |
New potential of ACE inhibitors in clinical practice |
Abstract
PDF (Rus)
|
D. V. Nebieridze, A. S. Safaryan |
|
Vol 9, No 5 (2010) |
Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results |
Abstract
PDF (Rus)
|
V. M. Gorbunov |
|
Vol 9, No 4 (2010) |
Thiazide diuretics: 50 years of history or looking into the future |
Abstract
PDF (Rus)
|
I. V. Fomin |
|
Vol 9, No 4 (2010) |
Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil |
Abstract
PDF (Rus)
|
V. I. Makolkin |
|
Vol 9, No 4 (2010) |
Combined therapy in metabolic syndrome treatment |
Abstract
PDF (Rus)
|
Yu. V. Zhernakova, V. B. Mychka, I. E. Chazova |
|
Vol 9, No 3 (2010) |
Alternative therapy interaction with warfarin: what doctors should know |
Abstract
PDF (Rus)
|
T. B. Kozlova, T. V. Taratuta, M. B. Aksenova, T. V. Khlevchuk |
|
Vol 9, No 3 (2010) |
Problems in treating patients with high-risk arterial hypertension: focussing on diastolic heart failure |
Abstract
PDF (Rus)
|
O. M. Drapkina |
|
Vol 9, No 2 (2010) |
Arterial endothelial dysfunction and its role for prognosis assessment in cardiovascular patients |
Abstract
PDF (Rus)
|
G. N. Soboleva, V. K. Fedulov, Yu. A. Karpov |
|
Vol 9, No 2 (2010) |
Large artery hemodynamics in elderly patients with arterial hypertension |
Abstract
PDF (Rus)
|
G. G. Efremushkin, T. V. Filippova, E. A. Denisova |
|
Vol 9, No 2 (2010) |
Metabolic effects of antihypertensive medications: prognostic role in the development of cardiovascular disease and diabetes mellitus |
Abstract
PDF (Rus)
|
M. V. Stroeva, M. N. Mamedov |
|
Vol 9, No 2 (2010) |
Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine? |
Abstract
PDF (Rus)
|
O. V. Averkov |
|
Vol 9, No 1 (2010) |
Could secondary prevention of coronary heart disease be more effective? |
Abstract
PDF (Rus)
|
V. I. Makolkin |
|
Vol 8, No 6 (2009) |
Perioperative beta-adrenoblocker therapy and cardiovascular event risk: are all the problems solved? |
Abstract
PDF (Rus)
|
Yu. M. Lopatin |
|
Vol 8, No 6 (2009) |
Therapy compliance and fixed-dose combinations in arterial hypertension treatment. Focus on a fixed-dose combination of felodipine and metoprolol |
Abstract
PDF (Rus)
|
S. A. Shalnova, S. K. Kukushkin, E. M. Manoshkina |
|
Vol 8, No 6 (2009) |
Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg |
Abstract
PDF (Rus)
|
A. N. Britov |
|
Vol 8, No 6 (2009) |
Methods of renal function assessment in arterial hypertension: the clinical value and practical implementation |
Abstract
PDF (Rus)
|
Zh. D. Kobalava, Yu. V. Kotovskaya, S. V. Villewalde |
|
Vol 8, No 6 (2009) |
Monitoring program for assessing population health and clinico-economical effectiveness of regional healthcare system |
Abstract
PDF (Rus)
|
S. V. Dobrykh, S. V. Alekseeva, O. Yu. Korennova, T. F. Khaysarov |
|
Vol 8, No 5 (2009) |
Statins in acute coronary syndrome |
Abstract
PDF (Rus)
|
O. M. Drapkina |
|
Vol 8, No 5 (2009) |
Animal proteins and atherosclerosis: a hypothesis |
Abstract
PDF (Rus)
|
E. N. Nikolaeva |
|
Vol 8, No 8 (2009) |
Coffee and cardiovascular risk: what is new? |
Abstract
PDF (Rus)
|
G. Ya. Maslennikova, R. G. Oganov |
|
Vol 8, No 4 (2009) |
Organisational technologies for ambulatory outpatient healthcare quality improvement in cardiovascular disease patients |
Abstract
PDF (Rus)
|
L. S. Barbarash, G. V. Artamonova, S. A. Makarov, O. V. Kovalenko, I. E. Koltunov |
|
Vol 8, No 4 (2009) |
Antihypertensive therapy in obese patients with arterial hypertension |
Abstract
PDF (Rus)
|
О. M. Drapkina, Yu. V. Dubolazova |
|
Vol 8, No 4 (2009) |
Compliance to cardiovascular treatment: clinicians and patients’ problem |
Abstract
PDF (Rus)
|
G. V. Pogosova, I. E. Koltunov, G. Yu. Melik-Ogandzhanyan, O. Yu. Sokolova |
|
Vol 8, No 8 (2009) |
Cardiovascular disease: statistical registration principles and international comparability |
Abstract
PDF (Rus)
|
I. V. Samorodskaya |
|
Vol 8, No 2 (2009) |
Clinical effects of statins: focusing on simvastatin |
Abstract
PDF (Rus)
|
D. M. Aronov, M. G. Bubnova |
|
Vol 8, No 2 (2009) |
Arterial hypertension in young people and adolescents: diagnostics and treatment |
Abstract
PDF (Rus)
|
O. A. Kislyak, E. V. Petrova, D. S. Sargaeva |
|
Vol 8, No 1 (2009) |
System inflammation role in cardiovascular and obstetric pathology |
Abstract
PDF (Rus)
|
M. B. Igitova, E. V. Wobieva, E. V. Osipova, N. P. Gol’tsova |
|
Vol 7, No 6 (2008) |
Body mass in men and women: the Russian national representative sample data |
Abstract
PDF (Rus)
|
S. A. Shalnova, A. D. Deev |
|
Vol 7, No 6 (2008) |
Perindopril arginine: a new ACE inhibitor salt increases therapeutic potential |
Abstract
PDF (Rus)
|
Yu. A. Karpov |
|
Vol 7, No 6 (2008) |
Non-differentiated connective tissue dysplasia. "Carthage should be destroyed"? |
Abstract
PDF (Rus)
|
E. V. Zemtsovsky |
|
Vol 7, No 7 (2008) |
Bisoprolol in cardiovascular disease treatment |
Abstract
PDF (Rus)
|
S. N. Tolpygina, S. Yu. Martsevich |
|
Vol 7, No 8 (2008) |
Will the BEAUTIFUL Study results change our views on heart rate control? |
Abstract
PDF (Rus)
|
Yu. M. Lopatin |
|
Vol 7, No 8 (2008) |
Myocardial infarction: how accurate are official statistics? |
Abstract
PDF (Rus)
|
L. A. Bokeriya, I. N. Stupakov, I. V. Samorodskaya, E. V. Bolotova, T. S. Ocheret |
|
Vol 7, No 8 (2008) |
Adding а thiazide diuretic to combined antihypertensive therapy is clinically reasonable |
Abstract
PDF (Rus)
|
V. I. Makolkin |
|
Vol 7, No 5 (2008) |
Stable angina diagnostics and treatment in elderly patients |
Abstract
PDF (Rus)
|
V. P. Lupanov, D. M. Aronov |
|
Vol 7, No 4 (2008) |
From combined therapy to fixed-dose combinations |
Abstract
PDF (Rus)
|
I. P. Kolos, S. A. Boytsov |
|
Vol 7, No 3 (2008) |
Modern principles of pharmaceutical treatment in patients with chronic coronary heart disease |
Abstract
PDF (Rus)
|
S. Yu. Martsevich |
|
Vol 7, No 3 (2008) |
Arterial hypertension and thyroid function compensation: pharmacotherapy aspects |
Abstract
PDF (Rus)
|
G. B. Selivanova |
|
Vol 7, No 2 (2008) |
Obesity effects on cardiovascular system |
Abstract
PDF (Rus)
|
I. G. Fomina, Z. O. Georgadze, A. E. Pokrovskaya, E. V. Shepeleva |
|
Vol 7, No 1 (2008) |
Modern views on clinical and economical effectiveness of rosuvastatin |
Abstract
PDF (Rus)
|
S. K. Zyryanov, Yu. B. Belousov |
|
Vol 7, No 1 (2008) |
Statin therapy compliance |
Abstract
PDF (Rus)
|
N. Sh. Zagidullin, Sh. Z. Zagidullin |
|
Vol 7, No 1 (2008) |
Statin choice for lipid6lowering therapy: clinical pharmacology and evidence-based medicine position |
Abstract
PDF (Rus)
|
S. V. Nedogoda |
|
Vol 6, No 6 (2007) |
Nifedipine effects on blood cells and rheology in arterial hypertension and pregnancy |
Abstract
PDF (Rus)
|
N. K. Runikhina, O. N. Tkacheva, B. Ya. Bart |
|
Vol 6, No 6 (2007) |
New approach to heart rate control as mortality reduction method in cardiac patients: potential of a new If inhibitor, ivabradine |
Abstract
PDF (Rus)
|
Yu. B. Belousov, O. A. Maneshina, S. B. Erofeeva |
|
Vol 6, No 6 (2007) |
Cardiovascular disease and ACE inhibitors: focusing on enalapril |
Abstract
PDF (Rus)
|
G. A. Baryshnikova |
|
Vol 6, No 6 (2007) |
New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use |
Abstract
PDF (Rus)
|
M. G. Bubnova |
|
Vol 6, No 6 (2007) |
Candesartan cilexetil in cardiovascular prevention |
Abstract
PDF (Rus)
|
A. Ya. Ivleva |
|
Vol 6, No 6 (2007) |
ASCOT study: consequences and lessons |
Abstract
|
S. A. Boytsov |
|
Vol 6, No 5 (2007) |
Improving prognosis in coronary heart disease patients after coronary bypass surgery |
Abstract
PDF (Rus)
|
E. V. Shlyakhto, A. V. Panov, M. L. Gordeev, B. A. Tatarsky, A. A. Totolyan |
|
Vol 6, No 4 (2007) |
Modern management of arterial hypertension: has the position of beta-adrenoblockers changed |
Abstract
PDF (Rus)
|
S. Yu. Martsevich |
|
Vol 6, No 4 (2007) |
Combined therapy of arterial hypertension: focus on pleiotropic effects |
Abstract
PDF (Rus)
|
D. B. Nebieridze |
|
Vol 6, No 4 (2007) |
Refractory angina: what to offer to our patients? |
Abstract
PDF (Rus)
|
S. N. Tereshchenko, I. V. Zhirov |
|
Vol 6, No 4 (2007) |
Vertigo in internist's practice |
Abstract
PDF (Rus)
|
O. M. Drapkina, S. M. Chaparkina, V. T. Ivashkin |
|
Vol 6, No 3 (2007) |
Paroxysmal atrial fibrillation: treatment choice |
Abstract
PDF (Rus)
|
B. A. Tatarsky |
|
Vol 6, No 3 (2007) |
Beta-adrenoblockers in clinical practice: is there any difference? |
Abstract
PDF (Rus)
|
D. V. Nebieridze, A. Meliya, G. R. Kulieva |
|
Vol 6, No 3 (2007) |
Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure |
Abstract
PDF (Rus)
|
E. V. Privalova |
|
Vol 6, No 3 (2007) |
Choosing optimal combination of neuro-humoral modulators in chronic heart failure: CHARM-Added study lessons |
Abstract
PDF (Rus)
|
Yu. M. Lopatin |
|
Vol 6, No 1 (2007) |
Arterial hypertension therapy effectiveness in smokers |
Abstract
PDF (Rus)
|
D. V. Nebieridze, F. A. Papova, N. S. Ivanishina, A. S. Safaryan, N. L. Vinnitskaya, A. Meliya |
|
Vol 6, No 1 (2007) |
Coronary heart disease treatment: old principles and new horizons |
Abstract
PDF (Rus)
|
Yu. A. Vasyuk, E. L. Shkol’nik |
|
Vol 5, No 6 (2006) |
Aspirin for thromboembolic complication prevention in cardiovascular disease: dose optimization and adverse effect minimization |
Abstract
PDF (Rus)
|
A. N. Britov |
|
Vol 5, No 6 (2006) |
ω3-polyunsarturated fatty acid medications in cardiovascular event prevention |
Abstract
PDF (Rus)
|
K. A. Talitsky, Yu. A. Karpov |
|
Vol 5, No 6 (2006) |
Cardiovascular risk factors and their control in early XXI century (REACH registry data) |
Abstract
PDF (Rus)
|
E. P. Panchenko |
|
Vol 5, No 6 (2006) |
Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin) |
Abstract
PDF (Rus)
|
R. G. Oganov, D. M. Aronov, M. G. Bubnova |
|
Vol 5, No 5 (2006) |
High-risk patient characteristics. Results of the OSCAR Study: epidemiological part |
Abstract
PDF (Rus)
|
S. A. Shalnova, A. D. Deev |
|
Vol 5, No 5 (2006) |
Non-pharmaceutical hypercholesterolemia management by plant stanol-enriched product consumption |
Abstract
PDF (Rus)
|
N. V. Perova |
|
Vol 5, No 5 (2006) |
Torasemide – loop diuretic with specific effects |
Abstract
PDF (Rus)
|
V. M. Gorbunov, R. G. Oganov |
|
Vol 5, No 5 (2006) |
Anxiety states in cardiac patients: diagnostics and treatment aspects |
Abstract
PDF (Rus)
|
G. V. Pogosova |
|
Vol 5, No 4 (2006) |
Improving arterial hypertension control in patients with high cardiovascular event risk: main stages of Russian Research and Clinical Program ARGUS-2 |
Abstract
PDF (Rus)
|
A. I. Martynov, V. S. Moiseev, R. G. Oganov, Zh. D. Kobalava, Yu. V. Kotovskaya, E. G. Starostina |
|
Vol 5, No 4 (2006) |
Pregnancy-associated plasma protein – a new biochemical marker of acute coronary syndrome and poor prognosis predictor in coronary heart disease patients |
Abstract
PDF (Rus)
|
O. P. Shevchenko, A. O. Shevchenko, E. V. Kochetova, O. V. Orlova |
|
Vol 5, No 4 (2006) |
Effective blood pressure control in arterial hypertension patients: the role of combined fixed-dose pharmaceutical therapy |
Abstract
PDF (Rus)
|
S. Yu. Martsevich, Yu. V. Lukina, N. S. Oganisyan |
|
Vol 5, No 3 (2006) |
Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons |
Abstract
PDF (Rus)
|
Yu. M. Lopatin |
|
Vol 5, No 3 (2006) |
Ivabradine – a new agent for coronary heart disease treatment |
Abstract
PDF (Rus)
|
O. A. Maneshina, S. B. Erofeeva, Yu B. Belousov |
|
Vol 5, No 3 (2006) |
New perspectives in improving prognosis after myocardial infarction |
Abstract
PDF (Rus)
|
N. M. Akhmedzhanov |
|
Vol 4, No 6, ч.II (2005) |
Ultrasound assessment of vasodilatory endothelial reactions in patients with Type 2 diabetes mellitus, associated with coronary heart disease and arterial hypertension |
Abstract
PDF (Rus)
|
Ya. V. Evseeva, T. E. Kurilskaya, A. A. Runovich |
|
Vol 4, No 5 (2005) |
Fatty acid and carbohydrate metabolism in acute myocardial ischemia |
Abstract
PDF (Rus)
|
M. A. Aripov, D. Kh. Kamardinov, S. V. Madoyan |
|
Vol 4, No 3, ч.I (2005) |
Modern principles of chronic coronary heart disease management. The role of antianginal medications |
Abstract
PDF (Rus)
|
S. Yu. Martsevich |
|
Vol 4, No 3, ч.I (2005) |
Antihypertensive therapy in patients with cerebrovascular pathology: actual aspects and rational approaches |
Abstract
PDF (Rus)
|
Z. A. Suslina, L. A. Geraskina, A. V. Fonyakin |
|
Vol 4, No 2 (2005) |
Urgent prevention in cardiovascular disease |
Abstract
PDF (Rus)
|
V. V. Ruksin |
|
Vol 8, No 7 (2009) |
Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent |
Abstract
PDF (Rus)
|
V. V. Rafalsky, A. V. Krikova, A. N. Baglikov |
|
Vol 5, No 7 (2006) |
Antianginal treatment of stable angina: focus on heart rate reduction |
Abstract
PDF (Rus)
|
Yu. M. Lopatin |
|
Vol 5, No 8 (2006) |
Abdominal obesity diagnostics in clinical practice |
Abstract
PDF (Rus)
|
E. N. Vorobyeva, I. V. Osipova, N. G. Veselovskaya, N. I. Mordvinova, R. I. Vorobyev |
|
Vol 5, No 7 (2006) |
Inflammation role in atrial fibrillation pathogenesis |
Abstract
PDF (Rus)
|
A. I. Tarzimanova, I. G. Fomina |
|
Vol 5, No 8 (2006) |
Beta-adrenoblocker in heart failure: bisoprolol role |
Abstract
PDF (Rus)
|
Yu. V. Lukina, S. Yu. Martsevich |
|
Vol 9, No 7 (2010) |
Could erectile dysfunction be a marker of atherosclerotic cardiovascular disease? |
Abstract
PDF (Rus)
|
G. G. Sharvadze, M. N. Mamedov, E. A. Poddubskaya, D. G. Kurbatov |
|
Vol 5, No 8 (2006) |
New perspectives of three-dimensional echocardiography in left ventricular assessment |
Abstract
PDF (Rus)
|
S. T. Matskeplishvili, Yu. I. Buziashvili |
|
Vol 5, No 7 (2006) |
New methods for dyslipidemia correction |
Abstract
PDF (Rus)
|
V. T. Ivashkin, O. M. Drapkina, A. V. Klimenkov |
|
Vol 10, No 8 (2011) |
Physical activity assessment in coronary heart disease patients: questionnaire ODA-23+ |
Abstract
PDF (Rus)
|
V. B. Krasnitskyi, D. M. Aronov, S. O. Dzhankhotov |
|
Vol 9, No 7 (2010) |
Ezetimibe potential in cardiology practice |
Abstract
PDF (Rus)
|
A. A. Lyakishev, A. E. Semenova, S. V. Miklishanskaya, V. V. Kukharchuk |
|
Vol 5, No 8 (2006) |
Emotions and the heart |
Abstract
PDF (Rus)
|
G. V. Pogosova, I. E. Koltunov, Yu. S. Belova, N. V. Skazin |
|
Vol 10, No 8 (2011) |
Therapeutic and biopharmaceutical assessment of indapamide medications |
Abstract
PDF (Rus)
|
G. V. Ramenskaya, S. V. Nedogoda, I. E. Shokhin, A. Yu. Savchenko, V. S. Shlykov |
|
Vol 9, No 7 (2010) |
ACE inhibitors in arterial hypertension treatment among various clinical groups |
Abstract
|
O. D. Ostroumova, M. L. Maksimov |
|
Vol 10, No 8 (2011) |
New non-pharmaceutical methods for the treatment of resistant arterial hypertension |
Abstract
PDF (Rus)
|
A. V. Rodionov, I. E. Shumilova, V. I. Makolkin |
|
Vol 9, No 8 (2010) |
Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination |
Abstract
PDF (Rus)
|
M. V. Leonova |
|
Vol 9, No 8 (2010) |
Nitric oxide role and endothelial dysfunction development in diabetes mellitus |
Abstract
PDF (Rus)
|
S. G. Dzugkoev, F. S. Dzugkoeva, V. A. Metelskaya |
|
Vol 9, No 8 (2010) |
Mitral valve prolapse: «Much Ado About Nothing», or a real unsolved problem? |
Abstract
PDF (Rus)
|
E. V. Zemtsovsky, E. G. Malev, S. V. Reeva |
|
Vol 5, No 7 (2006) |
Short QT interval syndrome |
Abstract
PDF (Rus)
|
I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzhsky |
|
Vol 9, No 8 (2010) |
Myocardial damage mechanisms in coronary artery bypass surgery (literature review) |
Abstract
PDF (Rus)
|
Sh. Kh. Samadov, I. V. Koksheneva |
|
Vol 6, No 8 (2007) |
Pharmaceutical therapy in patients with acquired aortic stenosis |
Abstract
PDF (Rus)
|
R. A. Abueva, V. V. Samoylenko, V. I. Makolkin |
|
Vol 10, No 7 (2011) |
Bisoprolol effectiveness in arterial hypertension and coronary heart disease |
Abstract
PDF (Rus)
|
O. D. Ostroumova, M. L. Maksimov, A. M. Rykova |
|
Vol 9, No 8 (2010) |
Assessment of the population demand for high-cost medical interventions: are there any reliable criteria? |
Abstract
PDF (Rus)
|
I. V. Samorodskaya |
|
Vol 6, No 8 (2007) |
Differential beta-adrenoblocker therapy in chronic heart failure |
Abstract
PDF (Rus)
|
S. N. Tereshchenko, A. V. Anikina, I. V. Zhirov, E. A. Kotaeva |
|
Vol 6, No 8 (2007) |
Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension |
Abstract
PDF (Rus)
|
N. M. Chikhladze, I. E. Chazova |
|
Vol 7, No 7 (2007) |
New targets for arterial hypertension control in patients with coronary heart disease: ESH/ESC guidelines on arterial hypertension management, 2007 |
Abstract
PDF (Rus)
|
Yu. A. Karpov |
|
Vol 7, No 7 (2007) |
Heart rate-lowering antianginal medications: what determines their choice? |
Abstract
PDF (Rus)
|
Yu. M. Lopatin |
|
Vol 8, No 7 (2009) |
Functional heart diseases – new realities |
Abstract
PDF (Rus)
|
Yu. M. Pozdnyakov, V. S. Volkov |
|
1 - 268 of 268 Items |
|